At ASU, clinical partnerships—which tie together researchers, healthcare practitioners and the community—lie at the intersection of social embeddedness and use-inspired research.
In biomedical research, ASU does not rely on a medical school for the crosstalk needed to trigger health-related innovations. Rather, ASU has created a network with its clinical partners —area hospitals and healthcare organizations—to provide inspiration, test innovations and real-world training for its students, and to bring research back to the community in which it exists. Visit https://clinicalpartnerships.asu.edu/ to learn more.
Clinical partnerships and collaborations are an important component for growth of the Biodesign Institute and capacity-building initiatives. Increasing involvement with non-government and such non-ASU researchers as the Bill and Melinda Gates Foundation, Mayo Clinic, Translational Genomics Research Institute (TGen) and Barrow Neurological Institute provides opportunities to expand and enhance our research and its relevance to society.
Although many of the Biodesign Institute’s activities are oriented to national and international perspectives, priority has also been given to building productive research collaborations with Arizona-based organizations. Included among these are the following supporting and collaborative organizations:
- The Virginia G. Piper Charitable Trust and Personalized Medicine Initiative. Piper Trust has invested in building regional distinction in biosciences, particularly personalized medicine. The initiative includes support for the Center for Sustainable Health and the Virginia G. Piper Center for Personal Diagnostics (both within the Biodesign Institute at Arizona State University). The Centers work to improve health outcomes at lower costs by sustaining health through the prevention and early detection of disease. Foremost researchers and faculty with the Center for Sustainable Heath, including Nobel laureate Dr. Leland Hartwell, and Director of the Virginia G. Piper Center for Personal Diagnostics and Piper Chair in Personalized Medicine Dr. Joshua LaBaer, promote Arizona as a magnet for personalized medicine internationally.
- Mayo Clinic. Biodesign, as well as the rest of ASU, have an active and extensive partnership with the Mayo Clinic Arizona. As an example, we have major research collaborations to develop new cancer biomarkers and diagnostics.
- BIO5 at the University of Arizona. The Institute has partnered with BIO5 on projects that include diabetes biomarkers, asthma, Valley Fever, and the rational design of molecular therapeutics. While TRIF allocation shortfalls have affected these projects, helpful working collaborations are in place.
- Science Foundation Arizona (SFAz) SFAz represents a crucial development in the ability of Arizona to achieve competitive status in the global research community. The Institute was successful in capturing funding in all of the new funding categories launched by SFAz in its first year of operations in 2006. Funding of Biodesign Institute activities represented 43% of the total monies awarded to ASU from SFAz, including the largest single investment to date by SFAz to accelerate the Tubes-in-the-Desert project. Since then, SFAz has awarded more than 150 individual grants totally over $110M, which has led to 1,865 direct jobs, 207 patents filed and/or issued, 24 technology companies formed in Arizona and 23 technology licenses in place. SFAz's research grants are highly leveraged, and generate at least $4 for every $1 of state funds invested.
- Biodesign Adjunct Faculty Members. Biodesign fosters relationships with more than 70 individual researchers across the state, country and world through our adjunct faculty program. This program is intended to advance the research program of the individual and to nurture collaborations.